Sheila Weiss Smith, Ph.D.
Pharmaceutical Health Services Research Department
University of Maryland Baltimore
Sheila Weiss Smith received a B.S. in Biology from University of Maine, Orono, an M.S. in Exercise Sciences from Northeastern University, and a Ph.D. in Epidemiology from the Johns Hopkins University. She completed a postdoctoral fellowship in Pharmacoepidemiology and Regulatory Sciences at the U.S. Food and Drug Administration and University of Maryland.
Dr. Weiss Smith currently directs the Center for Drug Safety, where she collaborates with other investigators on research in pharmacoepidemiology and drug safety. She also serves as a visiting scientist at the National Cancer Institute where she conducts research in the impact of prescription medicines on cancer risk as well as the safety of drugs used in cancer care. She consults to industry and government on pharmaceutical risk issues. She is a fellow in the International Society of Pharmacoepidemiology (ISPE) and serves on the editorial board for the journal Research in Social and Administrative Pharmacy. Dr. Weiss Smith teaches epidemiology and advanced pharmacoepidemiology methods at the University of Maryland and pharmacoepidemiology at Johns Hopkins School of Public Health’s Graduate Summer Institute.